Isabelle Cochereau

Summary

Affiliation: Centre Hospitalier Universitaire
Country: France

Publications

  1. ncbi request reprint [Unconventional transmissible agents]
    I Cochereau
    Service d Ophtalmologie, CHU d Angers, 4, rue Larrey, 49033 Angers Cedex 01
    J Fr Ophtalmol 27:414-6. 2004
  2. pmc Efficacy and safety of short duration azithromycin eye drops versus azithromycin single oral dose for the treatment of trachoma in children: a randomised, controlled, double-masked clinical trial
    Isabelle Cochereau
    Service d Ophtalmologie, CHU d Angers, 4, rue Larrey, 49033 Angers, France
    Br J Ophthalmol 91:667-72. 2007
  3. pmc 3-day treatment with azithromycin 1.5% eye drops versus 7-day treatment with tobramycin 0.3% for purulent bacterial conjunctivitis: multicentre, randomised and controlled trial in adults and children
    Isabelle Cochereau
    Service d Ophtalmologie, CHU d Angers, 4, rue Larrey, 49033 Angers, France
    Br J Ophthalmol 91:465-9. 2007
  4. ncbi request reprint [The risks of anti-infectious drugs]
    I Cochereau
    Service d Ophtalmologie, CHU d Angers, Angers, France
    J Fr Ophtalmol 30:414-6. 2007
  5. doi request reprint Efficacy and safety of azithromycin 1.5% eye drops for purulent bacterial conjunctivitis in pediatric patients
    Dominique Bremond-Gignac
    Service d Ophtalmologie, Centre Saint Victor, CHU d Amiens, Bd de Beauvillé, Amiens, Université Picardie Jules Verne, France
    Pediatr Infect Dis J 29:222-6. 2010

Detail Information

Publications5

  1. ncbi request reprint [Unconventional transmissible agents]
    I Cochereau
    Service d Ophtalmologie, CHU d Angers, 4, rue Larrey, 49033 Angers Cedex 01
    J Fr Ophtalmol 27:414-6. 2004
    ..This review describes how these recommendations are followed and tries to provide insights into improving daily practice with these unconventional transmissible agents...
  2. pmc Efficacy and safety of short duration azithromycin eye drops versus azithromycin single oral dose for the treatment of trachoma in children: a randomised, controlled, double-masked clinical trial
    Isabelle Cochereau
    Service d Ophtalmologie, CHU d Angers, 4, rue Larrey, 49033 Angers, France
    Br J Ophthalmol 91:667-72. 2007
    ..Efficacy and safety of a short-duration treatment of azithromycin 1.5% eye drops versus oral azithromycin to treat active trachoma...
  3. pmc 3-day treatment with azithromycin 1.5% eye drops versus 7-day treatment with tobramycin 0.3% for purulent bacterial conjunctivitis: multicentre, randomised and controlled trial in adults and children
    Isabelle Cochereau
    Service d Ophtalmologie, CHU d Angers, 4, rue Larrey, 49033 Angers, France
    Br J Ophthalmol 91:465-9. 2007
    ..To compare the efficacy and safety of Azyter, azithromycin 1.5% eye drops, for 3 days with tobramycin 0.3% for 7 days to treat purulent bacterial conjunctivitis...
  4. ncbi request reprint [The risks of anti-infectious drugs]
    I Cochereau
    Service d Ophtalmologie, CHU d Angers, Angers, France
    J Fr Ophtalmol 30:414-6. 2007
    ..The risk of toxicity is less important because it is well known, it is obvious when it occurs, and because it is an individual and nontransmissible risk...
  5. doi request reprint Efficacy and safety of azithromycin 1.5% eye drops for purulent bacterial conjunctivitis in pediatric patients
    Dominique Bremond-Gignac
    Service d Ophtalmologie, Centre Saint Victor, CHU d Amiens, Bd de Beauvillé, Amiens, Université Picardie Jules Verne, France
    Pediatr Infect Dis J 29:222-6. 2010
    ..In a subset of 150 children included in a large study having enrolled 1043 patients, our aim was to analyze in children, the efficacy and safety of azithromycin 1.5% eye-drops in the treatment of this disease...